Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

543
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
543
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

479
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
479

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrative profiling of oral fungal communities across <i>Mycobacterium Tuberculosis</i> burden groups in Xpert-positive patients.

Annals of medicine·2026
Same author

Diagnostic accuracy of GeneReady MTB assay on sputum for detecting pulmonary tuberculosis: a prospective multicenter study in China.

Journal of clinical microbiology·2026
Same author

An optimal processing method for recovery of tuberculosis in the tongue swab using the <i>Mycobacterium</i> growth indicator tube method.

Microbiology spectrum·2026
Same author

Near-point-of-care diagnosis of tuberculosis with LyocartE MTB Assay: a multicentre diagnostic accuracy study.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

<i>AceE</i> affects the optimum growth and biofilm formation of <i>Mycobacterium tuberculosis</i> via cell wall lipid remodeling.

mSystems·2026
Same author

Lipid accumulation in tuberculosis granulomas inhibits macrophage-CD4<sup>+</sup> T cell interactions and infection control.

Nature microbiology·2026

Related Experiment Video

Updated: Jan 17, 2026

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

8.3K

Using Machine Learning Methods to Predict Early Treatment Outcomes for Multidrug-Resistant or Rifampicin-Resistant

Fuzhen Zhang1,2,3, Zilong Yang4, Xiaonan Geng2

  • 1Department of Bacteriology and Immunology, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis & Thoracic Tumor Research Institute, Beijing, China.

Journal of Medical Internet Research
|September 22, 2025
PubMed
Summary
This summary is machine-generated.

Machine learning models accurately predict multidrug-resistant tuberculosis (MDR/RR-TB) treatment outcomes using early culture conversion data. The artificial neural network model shows superior performance for enhancing patient prognoses and control strategies.

Keywords:
artificial intelligenceculture conversionmachine learningmultidrug-resistant or rifampicin-resistant tuberculosispredictiontherapeutic efficacy

More Related Videos

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

9.0K
Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

13.2K

Related Experiment Videos

Last Updated: Jan 17, 2026

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

8.3K
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

9.0K
Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

13.2K

Area of Science:

  • Medical Informatics
  • Infectious Diseases
  • Machine Learning in Healthcare

Background:

  • Early prediction of treatment outcomes for multidrug-resistant or rifampicin-resistant tuberculosis (MDR/RR-TB) is critical for patient prognosis and disease transmission control.
  • Validated predictive models for MDR/RR-TB treatment outcomes are currently lacking, posing a significant challenge.

Purpose of the Study:

  • To compare logistic regression with machine learning (ML) models for predicting MDR/RR-TB treatment outcomes at 2 and 6 months.
  • To improve predictive model applications, refine control strategies, and increase MDR/RR-TB cure rates.

Main Methods:

  • Retrospective analysis of 744 patients (internal cohort) and 137 patients (external cohort) with MDR/RR-TB.
  • Development and validation of logistic regression and 7 ML models to predict culture conversion at 2 and 6 months.
  • Performance evaluation using area under the curve, accuracy, sensitivity, and specificity.

Main Results:

  • The artificial neural network model demonstrated superior performance in predicting culture conversion at both 2 and 6 months (AUC 0.82-0.90).
  • The model achieved high accuracy, sensitivity, and specificity, outperforming traditional logistic regression.
  • Culture conversion rates at 2 and 6 months were 81.9% and 87.1% respectively in the internal cohort.

Conclusions:

  • Machine learning models, particularly the artificial neural network, accurately predict MDR/RR-TB treatment outcomes based on early culture conversion.
  • These ML models offer a rapid and effective tool for evaluating therapeutic efficacy in early stages of MDR/RR-TB treatment.
  • ML models demonstrate superior stability and generalizability compared to logistic regression for MDR/RR-TB outcome prediction.